Developing and Validation of a High-Performance Liquid Chromatography Method for the Determination of Combined Perindopril, Indapamide and Amlodipine from Pharmaceutical Preparations

Year 2024, Volume: 44 Issue: 4, 306 - 317, 01.12.2024

Sevinç Ayla Özsar , Sacide Altınöz

https://doi.org/10.52794/hujpharm.1445884

Abstract

High Performance Liquid Chromatographic method was developed and validated for the analysis of a pharmaceutical preparation (TRIPLIXAM®) consist of Perindopril (PRN), İndapamide (IND) and Amlodipine (AML) which are used for the control of hypertension in patients with high blood pressure. In this developed HPLC method, ACE 5 C18 analytical column (12.5 x 4.6 mm) was used for the analysis of PRN, IND and AML. Acetonitril and 50 mM phosphate buffer mixture (40:60 v/v) was used as mobile phase. Measurements were obtained at 215 nm wavelength using UV detector. Retention times of PRN, AML and IND were 2.22, 3.48 and 5.05 min. respectively, at selected chromatographical conditions. The developed HPLC method was validated in terms of stability, accuracy, sensitivity, linearity, precision, specificity, ruggedness and robustness in accordance with ICH analytical method. Linear calibration curves were obtained in the range of 1.0-25.0 ppm; 1.0-8.0 ppm and 1.0-40.0 ppm for PRN, IND and AML, respectively. In this HPLC method the limit of dedection values (LOD) for PRN, IND and AML were 0.25 ppm, 0.10 ppm and 0.15 ppm while limit of quantification values (LOQ) were 0.50 ppm, 0.25 ppm and 0.40 ppm, respectively.

Keywords

Amlodipine, High Performance Liquid Chromatography, Indapamide, Perindopril, Validation

References

• 1. Servier İlaç ve Araştırma A.Ş. [cited June 2016]. Avaliable from: http://www.servier.com.
• 2. Türk Kardiyoloji Derneği. Türk Kardiyoloji Derneği Ulusal Hipertansiyon Tedavi ve Takip Kılavuzu. 1999. [cited Jully 2016]. Avaliable from: http://www.tkd.org.tr.
• 3. Medenica M, Ivanovic D, Maskovic M, Jancic B and Malenovic A. Evaluation of impurities level of perindopril tert-butylamine in tablets. J. Pharm. Biomed. Anal. 2007;44:1087–1094. https://doi.org/10.1016/j.jpba.2007.05.008
• 4. Simoncic Z, Roskar R, Gartner A, Kogej K ve Kmetec V. The use of microcalorimetry and HPLC for the determination of degradation kinetics and thermodynamic parameters of Perindopril Erbumine in aqueous solutions. Int. J. Pharm. 2008;356(1-2):200–205. http://dx.doi.org/10.1016/j.ijpharm.2008.01.031
• 5. El-Gizawy SM, Abdelmageed OH, Deryea SM, Omar MA and Abdel-Megied AM. Chiral separation of perindopril erbumine enantiomers using high performance liquid chromatography and capillary electrophoresis. Anal. Methods. 2014;6(3):825–830. http://dx.doi.org/10.1039/c3ay42056f
• 6. Maskovic M, Dotsikas Y, Malenovic A, Jancic-Stojanovic B, Ivanovic D and Medenica M. Desirability-based optimization and its sensitivity analysis for the perindopril and its impurities analysis in a microemulsion LC system. Microchem. J. 2011;99(2): 454–460. https://doi.org/10.1016/j.microc.2011.06.022
• 7. Katalin KE, Kelemen LJ, Gyeresi A, Silvia I and Mona O. Screening the Dissolution Performance of the Modified Release Tablets Containing Insoluble Active Substance in Different Dissolution Media. Acta Med Marisiensi. 2012;58(6):401-404.
• 8. Legorburu MJ, Alonso RM, Jiménez RM and Ortiz E. Quantitative Determination of Indapamide in Pharmaceuticals and Urine by High Performance Liquid Chromatography with Amperometric Detection. J. Chromatogr. Sci. 1999;37(8):283-287. https://doi.org/10.1093/chromsci/37.8.283
• 9. Kumar SA, Debnath M, Seshagiri Rao JVLN and Sankar DG. A new and rapid analytical method development & validation for simultaneous estimation of hydrochlorothiazide, amlodipine & olmesartan in tablet dosage form by using RP-HPLC. J. Chem. Pharm. Res. 2014;6(5):1208-1213.
• 10. Patel J and Patel M. RP-HPLC method development and validation for the simultaneous estimation of ramipril and amlodipine besylate in capsule dosage form. J. Chem. Pharm. Res. 2014;6(6):725-733.
• 11. Ubale M. RP-HPLC Method for Simultaneous Determination of Amlodipine Besylate and Atorvastatin Calcium: Application to Commercially available drug products. Int. Arch. App. Sci. Technol. 2014; 5(1):22-27.
• 12. Elshanawane AA, Abdelaziz LM, Kamal MM and Hafez HM. Quantitative Determination of Telmisartan, Ramipril, Amlodipine Besylate and Atorvastatin Calcium by HPLC. J. Liq. Chromatogr. R.T. 2014;37(2):195–206. https://doi.org/10.1080/10826076.2012.738622
• 13. Peikova LP, Tsvetkova BG, Kostova BD and Rache DR. Investigations and HPLC Assay of Model Formulations Containing Amlodipine Besylate and Lisinopril. Int. J. Pharm. Sci. Rev. Res. 2013;20:11-15.
• 14. Alagar RM, Ragavendra P, Banji D, Rao KNV, Chaithanya Y, Anusha B and Selvakumar D. RP-HPLC Method for Simultaneous Estimation of Aliskiren Hemi Fumarate, Hydrochlorothiazide and Amlodipine in Pharmaceutical Bulk Drugs and Tablet Dosage Form. J. Pharm. Res. 2012;5(8):4580-4584.
• 15. Shaalan RA, Belal TS, El Yazbi FA and Elonsy SM. Validated Stability-İndicating HPLC-DAD Method of Analysis for The Antihypertensive Triple Mixture of Amlodipin Besylate, Valsartan and Hydrochlorothiazide in Their Tablets. Arab. J. Chem. 2017;10:S1381-S1394. https://doi.org/10.1016/j.arabjc.2013.04.012
• 16. Nalluri BN, Naik DV, Sunandana B, Sushmith K. Development and validation of RP-HPLC-PDA method for the simultaneous estimation of hydrochlorothiazide, amlodipine besylate and olmesartan medoxomil in bulk and pharmaceutical dosage forms. J. Chem. Pharm. Res. 2013;5(1):329-335.
• 17. Sinojiya RS, Khasia V, Patel BJ, Dangi AA. Development and Validation of Rp-HPLC Method for the Simultaneous Determination of Telmisartan, Amlodipine Besylate & Hydrochlorothiazide in a Tablet Dosage Form. J. Pharm. Res. 2012 5(8):4154-4157.
• 18. Kochar NI, Dahake MN, Bakal RL, Devani AP, Chandewar AV. Method Development and Validation of Ramipril and Amlodipine Besylate by RP-HPLC. Asian J. Sci. Res. 2011; 4(12):1829-1832.
• 19. Tamboli AM, Chavan C, Mohite SK. Development and Validation of a RP- HPLC method for simultaneous determination of Amlodipine Besylate and Enalapril Maleate. J. Pharm. Res. 2010;3(11):2564-2567.
• 20. Khomushku GM, Zhloba AA, Puchnin VS, Arkhipova MV, Moiseeva SM. Analyses of the Angiotensin-Converting Enzyme Inhibitors Perindopril, Lisinopril and Quinapril by HPLC. Pharm Chem J. 2011;44(11):619-623. https://doi.org/10.1007/s11094-011-0531-0
• 21. El-Gindy A, Nassar MW, Abdel-Salam Attia K, Abu-Seada H, El-Ghandour M. Stability-Indicating HPLC Method for Simultaneous Determination of Captopril, İndapamide and Their Related Compounds. J. Liq. Chromatogr. R.T.2014;37(5):696–712. https://doi.org/10.1080/10826076.2012.758138
• 22. Parusu T, Ponneri V. RP‐HPLC method for simultaneous determination of atenolol and indapamide in pharmaceutical dosage forms, human blood and milk. Eur. J. Chem. 2012;3(2):138-142. https://doi.org/10.5155/eurjchem.3.2.138-142.537
• 23. Rani GT, Sankar DG, Kadgapathi P, Satyanarayana B. A Validated RP-HPLC method for simultaneous estimation of atenolol and indapamide in pharmaceutical formulations. Eur. J. Chem. 2011;8(3):1238-1245. https://doi.org/10.1155/2011/121420
• 24. Kadian N, Maste M, Bhat AR. An Effective RP-HPLC Method for the Simultaneous Determination of Atenolol and Indapamide in Marketed Tablet Formulation. Asian J. Chem. 2012;5(3):405-408.
• 25. Munot NM, Ghante MR, Deshpande AS, Gaikwad PV. Development and validation of RP-HPLC Method For Simultaneous Estimation of Indapamide and Telmisartan. J. Pharm. Res. 2010;3(12):2941-2943.
• 26. Basu A, Das B, Basak K, Chakraborty M, Basu S. Development & Validation of Stability Indicating High Performance Liquid Chromatographic Method for Simultaneous Estimation of Atenolol & Indapamide in Tablet Dosage Form. J. Pharm. Res. 2011;4(6):1677-1680.
• 27. Baheti KG, Shah N, Shaikh S. Ion-Pairing Reverse-Phase High Performance Liquid Chromatography Method for Simultaneous Estimation of Atenolol and Indapamide in Bulk and Combined Dosage Form. Indian J. Pharm. Sci. 2012; 74(3), 271–274.
• 28. Zaazaa HE, Abbas SS, Essam HAM and El-Bardicy MG. Validated chromatographic methods for determination of perindopril and amlodipine in pharmaceutical formulation in the presence of their degradation product. J. Chromatogr. Sci. 2013;51:533–543. https://doi.org/10.1093/chromsci/bms171
• 29. Gumieniczek A, Mączka P, Inglot T, Pietras R, Lewkut E, Perczak K. New HPLC method for in-vitro dissolution study of antihypertensive mixture amlodipine and perindopril using an experimental Design. Cent. Eur. J. Chem. 2013;11(5):717-724. https://doi.org/10.2478/s11532-013-0201-z
• 30. Gizawy SM, Bebawy LI, Abdelmageed OH, Omar MA, Deryea SM, Abdel-Megied AM. High performance liquid chromatography, TLC-densitometry and first derivative spectrophotometry for simultaneous determination of amlodipine and perindopril in bulk powder and its tablets. J. Liq. Chromatogr. R.T. 2013;36(10):1323-1339. https://doi.org/10.1080/10826076.2012.686141
• 31. Gumustas M. A Validated stability-indicating RP-LC method for the simultaneous determination of amlodipine and perindopril in tablet dosage form and their stress degradation behavior Under ICH-recommended stress conditions. J. AOAC Int.2013;96(4):751-757. https://doi.org/10.5740/jaoacint.11-010
• 32. Prajapati J, Patel A, Patel MB, Prajapati N, Prajapati R. Analytical method development and validation of Amlodipine besylate and Perindopril erbumine in combine dosage form by RP-HPLC. Int. J. Pharm. Sci. Res. 2011;3(2):801-808.
• 33. Jain PS, Badreshiya PR, Chalıkwar SS, Todarwal AA, Surana SJ. Validation of a dissolution method with RP-HPLC analysis for perindopril erbumin and indapamide combination tablet. Chem. Ind. Chem. Eng. Q. 2012;18(1):19−25. https://doi.org/10.2298/CICEQ110628042J
• 34. Pathak AK, Lodhi R, Shikhri MK. A Selective Reverse Phase HPLC Method For Simultaneous Determination of Perindopril and Indapamide In Solid Dosage Form And Bulk Drug. J. Pharm. Res. 2011; 4(8), 2512-2513.
• 35. Erk N. Comparison of spectrophotometric and an LC method for the determination perindopril and indapamide in pharmaceutical formulations. J. Pharm. Biomed. Anal. 2001;26:43-52. https://doi.org/10.1016/S0731-7085(01)00388-0
• 36. Bhadani S, Sellappan M. Development and Validation of RP-HPLC Method for Simultaneous Estimation of Perindopril Erbumine and İndapamide in Combined Dosage Form. Am. J. Pharm. Educ. 2013; 3(3), 703-711.
• 37. Jogia H, Khandelwal U, Gandhi T, Singh S, Modi D. Development and validation of a stability-indicating assay method for simultaneous determination of perindopril and indapamide in combined dosage form by reversed-phase high-performance liquid chromatography. J. AOAC Int. 2010;93(1):108-115. https://doi.org/10.1093/jaoac/93.1.108
• 38. Joseph J, Philip B, Sundarapandıan M. Method development and validation for simultaneous estimation of perindopril erbumine and indapamide by RP-HPLC in pharmaceutical dosage forms. Int. J. Pharm. Sci. 2011; 3(4).
• 39. Patel DB, Mehta FA, Bhatt KK. Simultaneous Estimation of Amlodipine Besylate and Indapamide in a Pharmaceutical Formulation by a High Performance Liquid Chromatographic (RP-HPLC) Method. Sci. Pharm. 2012;80:581–590. https://doi.org/10.3797/scipharm.1203-07
• 40. Mahajan SM, Chaple DR, Asnani AJ, Dhole SM. Development of RP-HPLC Method for Estimation of Indapamide and Amlodipine Besylate in Pharmaceutical Formulation. Asian J. Chem. 2012;5(6):738-741.
• 41. Kaila HO, Ambasana MA, Shah AK. Development and Validation of a Reversed-Phase Ultra-Performance Liquid Chromatographic Method for the Simultaneous Determination of Six Drugs Used for Combined Hypertension Therapy. J. AOAC Int. 2013;96(2):295-300. https://doi.org/10.5740/jaoacint.10-466
• 42. ICH. (2023). Validation of Analytical Procedures Q2(R2). Harmonized Tripartite Guideline.
• 43. The United States Pharmacopeia. (2005). Rockville: The national formulary, United States Pharmacopeial Convention.
• 44. El-Bagary RI, Elkady EF, Mowaka S, Attallah MA. A Validated HPLC Method for Simultaneous Determination of Perindopril Arginine, Amlodipine, and Indapamide: Application in Bulk and in Different Pharmaceutical Dosage Forms. J. AOAC Int. 2017; 100:992–999. https://doi.org/10.5740/jaoacint.16-0279
• 45. Chaudhary BR and Dave JB. Estimation of Perindopril Arginine, Indapamide and Amlodipine in Bulk and Fixed Dose Combination Using Stability Indicating Reverse Phase High-Pressure Liquid Chromatography. Int. J. Pharm. Sci. Res. 2020;11(12): 6267-6278. https://doi.org/10.13040/IJPSR.0975-8232.11(12).6267-78
• 46. Metwally MB, Khater DF, Abu-Nameh ESM, AlRashdan Y, Qaisi AM and Salim M. Simultaneous Determination of Indapamide, Amlodipine Besylate and Perindopril Arginine Combined in Tablet Dosage Form Using High Performance Liquid Chromatography. Jordan J. Pharm. Sci. 2020;13(4).
• 47. Swamy GK, Kumar JMR and Rao JS. Development and Validation of a Novel Stability Indicating RPHPLC Method for Simultaneous Estimation of Perindopril, Indapamide and Amlodipine in Bulk and Combined Tablet Dosage Forms. World J. Pharm. Res. 2015;4(6):2440-56.
• 48. Patel KP, Chhalotiya UK, Kachhiya HM and Patel JK. A new RP–HPLC method for simultaneous quantification of perindopril erbumine, indapamide, and amlodipine besylate in bulk and pharmaceutical dosage form. Future J. Pharm. Sci. 2020;6:1-9. https://doi.org/10.1186/s43094-020-00092-4
• 49. Karadurmus L, Gumustas M, Kurbanoglu S, Uslu B, Ozkan SA. A Novel Core-Shell-Based Chromatographic Method Supported by Ratio Derivative Spectrophotometry for The Simultaneous Determination of Perindopril, Indapamide, and Amlodipine Ternary Mixtures. Turk. J. Chem. 2018;42:1408-1419. https://doi.org/10.3906/kim-1712-9